ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,111, issued on April 22, was assigned to KSQ Therapeutics Inc. (Lexington, Mass.).
"Gene-regulating compositions and methods for improved immunotherapy" was invented by Micah Benson (Lexington, Mass.), Jason J. Merkin (Lexington, Mass.), Gregory V. Kryukov (Lexington, Mass.), Solomon Martin Shenker (Lexington, Mass.), Michael R. Schlabach (Lexington, Mass.), Noah Jacob Tubo (Lexington, Mass.) and James Martin Kaberna II (Lexington, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods and compositions related to the modification of immune effector cells to increase therapeutic efficacy. In some embodiments, immu...